We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Innovate Biopharmaceuticals Inc | NASDAQ:INNT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.56 | 0.56 | 0.57 | 0 | 01:00:00 |
Delaware
|
|
001-37797
|
|
27-3948465
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02.
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Item 5.03.
|
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
|
Item 5.07.
|
Submission of Matters to a Vote of Security Holders.
|
Nominee
|
For
|
Withheld
|
Broker Non-Votes
|
|||
Lorin K. Johnson, Ph.D.
|
15,555,113
|
|
214,506
|
|
2,791,010
|
|
Roy Proujansky, M.D.
|
15,686,957
|
|
82,662
|
|
2,791,010
|
|
Anthony E. Maida, Ph.D.
|
15,491,901
|
|
277,718
|
|
2,791,010
|
|
Saira Ramasastry, M.S., M. Phil.
|
15,456,636
|
|
312,983
|
|
2,791,010
|
|
Christopher Prior, Ph.D.
|
15,579,915
|
|
189,704
|
|
2,791,010
|
|
Jay Madan, M.S.
|
15,419,657
|
|
349,962
|
|
2,791,010
|
|
Sandeep Laumas, M.D.
|
15,365,793
|
|
403,826
|
|
2,791,010
|
|
For
|
Against
|
Abstain
|
14,443,812
|
1,280,117
|
45,690
|
For
|
Against
|
Abstain
|
14,581,637
|
1,162,866
|
25,116
|
For
|
Against
|
Abstain
|
14,889,385
|
875,460
|
4,774
|
For
|
Against
|
Abstain
|
14,805,480
|
960,013
|
4,126
|
For
|
Against
|
Abstain
|
14,737,098
|
1,024,656
|
7,865
|
For
|
Against
|
Abstain
|
14,702,184
|
1,061,138
|
6,297
|
For
|
Against
|
Abstain
|
14,824,057
|
939,834
|
5,728
|
For
|
Against
|
Abstain
|
15,616,937
|
147,965
|
4,717
|
For
|
Against
|
Abstain
|
18,486,063
|
62,278
|
12,288
|
Item 9.01.
|
Financial Statements and Exhibits.
|
|
|
|
|
Innovate Biopharmaceuticals, Inc.
|
|
|
|
|
Date: December 10, 2018
|
By:
|
/s/ Jay P. Madan
|
|
|
Jay P. Madan
|
|
|
President and Chief Business Officer
|
1 Year Innovate Biopharmaceutic... Chart |
1 Month Innovate Biopharmaceutic... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions